Skip to main content

PRCT

Stock
Health Care
Medical Devices

Performance overview

PRCT Price
Price Chart

Forward-looking statistics

Beta
0.84
Risk
63.94%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets areĀ based in the United States. Its revenue isĀ generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Company info

SectorHealth Care
IndustryMedical Devices
Employees493
Market cap$3.5B

Fundamentals

Enterprise value$3.0B
Revenue$249.1M
Revenue per employee—
Profit margin-36.20%
Debt to equity21.02

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.69
Dividend per share$0.48
Revenue per share$4.69
Avg trading volume (30 day)$36M
Avg trading volume (10 day)$30M
Put-call ratio—

Macro factor sensitivity

Growth-2.0
Credit+5.2
Liquidity-1.3
Inflation-2.6
Commodities-0.6
Interest Rates-2.1

Valuation

Dividend yield0.84%
PEG Ratio-43.55
Price to sales12.86
P/E Ratio-43.55
Enterprise Value to Revenue11.85
Price to book8.23

Upcoming events

Next earnings dayApril 24, 2025
Next dividend day—
Ex. dividend dayMarch 31, 2025

News

PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.51 per share a year ago.

Zacks Investment Research (April 24, 2025)
Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

PROCEPT BioRobotics PRCT stock is trading on Monday after the company released better-than-expected third-quarter earnings.

Benzinga (October 28, 2024)
Opening Bell, September 16, 2021

ForgeRock rings the opening bell at the New York Stock Exchange while Procept Biorobotics rings the opening bell at the Nasdaq.

CNBC Television (September 16, 2021)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free